Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts - PubMed (original) (raw)
. 1981 Sep 25;256(18):9501-10.
- PMID: 7287696
Free article
Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts
D A Haber et al. J Biol Chem. 1981.
Free article
Abstract
We have studied a line of 3T6 mouse embryo fibroblasts grown in progressively increasing concentrations of methotrexate. Resistance of cells to low concentrations of the inhibitor (less than 5 X 10(-5) M) is attributed to selective multiplication of the genes coding for dihydrofolate reductase and the resulting elevation of enzyme content. Cells isolated at a higher methotrexate concentration (4 X 10(-4) M) contain high levels of a dihydrofolate reductase with a reduced affinity for methotrexate. The altered dihydrofolate reductase exhibits a 270-fold reduction in binding affinity for methotrexate as measured by equilibrium dialysis (Kd = 5.4 X 10(-8) M versus 2 X 10(-10) M for the wild type enzyme). While binding to NADPH is unchanged, the Km for dihydrofolate is increased 3-fold over wild type enzyme and the turnover number for the reduction of dihydrofolate to tetrahydrofolate is decreased 20-fold. The altered dihydrofolate reductase shows a broader and more predominant acidic peak in its pH profile for this reaction. The molecular weights of the altered and wild type enzymes are identical as determined by sodium dodecyl sulfate-gel electrophoresis, but 2-dimensional electrophoresis reveals a significant basic shift in the migration of the altered enzyme. Studies with various folic acid analogs suggest that modifications involving the para-aminobenzoyl moiety of the inhibitor molecules are associated with the most dramatic differential binding between the altered and wild type dihydrofolate reductases.
Similar articles
- Site-directed mutagenesis of mouse dihydrofolate reductase. Mutants with increased resistance to methotrexate and trimethoprim.
Thillet J, Absil J, Stone SR, Pictet R. Thillet J, et al. J Biol Chem. 1988 Sep 5;263(25):12500-8. J Biol Chem. 1988. PMID: 3045118 - Characterization of the coexisting multiple mechanisms of methotrexate resistance in mouse 3T6 R50 fibroblasts.
Assaraf YG, Feder JN, Sharma RC, Wright JE, Rosowsky A, Shane B, Schimke RT. Assaraf YG, et al. J Biol Chem. 1992 Mar 25;267(9):5776-84. J Biol Chem. 1992. PMID: 1372892 - Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea.
Brown PC, Tlsty TD, Schimke RT. Brown PC, et al. Mol Cell Biol. 1983 Jun;3(6):1097-107. doi: 10.1128/mcb.3.6.1097-1107.1983. Mol Cell Biol. 1983. PMID: 6877240 Free PMC article. - Methotrexate resistant cells as targets for selective chemotherapy.
Bertino JR, Mini E, Sobrero A, Moroson BA, Love T, Jastreboff M, Carmen M, Srimatkandada S, Dube S. Bertino JR, et al. Adv Enzyme Regul. 1985;24:3-11. doi: 10.1016/0065-2571(85)90066-4. Adv Enzyme Regul. 1985. PMID: 3915186 Review.
Cited by
- Construction of a new vector conferring methotrexate resistance in Nicotiana tabacum plants.
Irdani T, Bogani P, Mengoni A, Mastromei G, Buiatti M. Irdani T, et al. Plant Mol Biol. 1998 Aug;37(6):1079-84. doi: 10.1023/a:1006082815434. Plant Mol Biol. 1998. PMID: 9700079 - Methotrexate does not block import of a DHFR fusion protein into chloroplasts.
America T, Hageman J, Guéra A, Rook F, Archer K, Keegstra K, Weisbeek P. America T, et al. Plant Mol Biol. 1994 Jan;24(2):283-94. doi: 10.1007/BF00020168. Plant Mol Biol. 1994. PMID: 8111032 - In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics.
Rana RM, Rampogu S, Abid NB, Zeb A, Parate S, Lee G, Yoon S, Kim Y, Kim D, Lee KW. Rana RM, et al. Molecules. 2020 Jul 31;25(15):3510. doi: 10.3390/molecules25153510. Molecules. 2020. PMID: 32752079 Free PMC article. - Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity.
Vannice JL, Levinson AD. Vannice JL, et al. J Virol. 1988 Apr;62(4):1305-13. doi: 10.1128/JVI.62.4.1305-1313.1988. J Virol. 1988. PMID: 2831391 Free PMC article. - Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell leukemia Jurkat cells.
Uchiyama H, Sowa Y, Wakada M, Yogosawa M, Nakanishi R, Horinaka M, Shimazaki C, Taniwaki M, Sakai T. Uchiyama H, et al. Cancer Sci. 2010 Mar;101(3):728-34. doi: 10.1111/j.1349-7006.2009.01449.x. Epub 2009 Nov 27. Cancer Sci. 2010. PMID: 20059476 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources